Diversity & Clinical Trials: Access &Trust


Jun. 22 2021, Published 8:00 p.m. ET

Link to TwitterLink to FacebookLink to Email



COST: free

VENUE: Virtual


Get Tickets

Join Newlab on June 23rd at 12:00PM ET for part one of Diversity & Clinical Trials, Access & Trust. A panel will investigate how recurring challenges in patient access to clinical trials affect study design, recruitment & retention, and diversity in data sets. What efforts should trial stakeholders explore to build trust and encourage buy-in into the trial process amongst diverse communities that are continually underrepresented?

Moderated by:

  • Kimberly Tableman — CEO, Medicine X
Article continues below advertisement

Featuring special guests:

  • Ramona Burress — Associate Director, Diversity & Inclusion in Clinical Trials, The Janssen Pharmaceutical Companies of Johnson & Johnson
  • Eric Roberts — Vice President, Trial Diversity & Inclusion, Hū
  • Sophia Goodison —Director, Oncology, Safety Evaluation and Risk Management (SERM) Scientist, GSK



Latest Event News and Updates

    Link to InstagramLink to FacebookLink to TwitterLinkedIn IconContact us by Email
    Black OwnedFemale Founder